Stocktoria
LINDE PLC LIN
Nasdaq · XNAS · stock · Industrial Inorganic Chemicals · website · IPO 2018-10-31
LINDE PLC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $34.0B | $33.0B | $32.9B | $33.4B | $30.8B |
| R&D expense | $147.0M | $150.0M | $146.0M | $143.0M | $143.0M |
| SG&A expense | $3.4B | $3.3B | $3.3B | $3.1B | $3.2B |
| Operating income | $8.9B | $8.6B | $8.0B | $5.4B | $5.0B |
| Income tax | $2.0B | $2.0B | $1.8B | $1.4B | $1.3B |
| Net income | $6.9B | $6.6B | $6.2B | $4.1B | $3.8B |
| EPS (diluted) | $14.61 | $13.62 | $12.59 | $8.23 | $7.33 |
| Operating cash flow | $10.3B | $9.4B | $9.3B | $8.9B | $9.7B |
| Free cash flow | $5.1B | $4.9B | $5.5B | $5.7B | $6.6B |
| Cash & equivalents | $5.1B | $4.8B | $4.7B | $5.4B | $2.8B |
| Inventory | $2.1B | $1.9B | $2.1B | $2.0B | $1.7B |
| Total assets | $86.8B | $80.1B | $80.8B | $79.7B | $81.6B |
| Total liabilities | $47.1B | $40.7B | $39.7B | $38.3B | $36.2B |
| Shareholders' equity | $39.7B | $39.5B | $41.1B | $41.4B | $45.4B |
Source: SEC EDGAR filings · CIK 0001707925 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.